Targeting neurodegenerative diseases with risuteganib as treatment therapy
May 3rd 2021ARVO
Glenn J. Jaffe, MD, discusses the key points of his virtual presentation on targeting neurodegenerative diseases with risuteganib, minimizing damage to the retina when compromised, and the need for newer treatment therapies to target different pathways.
Analyzing an investigational ophthalmic solution for treating presbyopia-related symptoms
December 13th 2020AAO
Michael R. Robinson, MD, Allergan, discusses the results from a study analyzing an investigational ophthalmic solution for treatment of symptoms associated with presbyopia presented during the virtual AAO 2020 meeting.
Evaluating long-term safety of micro-bypass implant + phaco in PXG
December 12th 2020AAO
Tanner Ferguson, MD, Cole Eye Institute, discusses findings from the study "Trabecular Micro-bypass Stent Implantation (iStent)" + Phacoemulsification in PXG: Six-Year Outcomes," during the virtual AAO 2020 meeting.
Drug delivery vs drops: Controlling postop pain, inflammation in cataract patients
December 8th 2020AAO
John A. Hovanesian, MD, discusses the highlights of his presentation on a clinical study evaluating dexamethasone vs prednisolone acetate 1% in controlling postop pain/inflammation in sequential cataract surgery patients.
AAO 2020: Fingolimod for MS offers disease control with no development of uveitis
November 15th 2020AAO
Bradley Smith, MD, presents at AAO 2020 on how fingolimod 0.5 mg, a first-line treatment for multiple sclerosis, may reduce both the number of relapses and disease progression in patients with relapsing-remitting MS as well as the incidence of uveitis.
AAO 2020: Drop-free prophylaxis regimen before cataract surgery lowers treatment burden with caveats
November 15th 2020AAO
During AAO 2020, Neal H. Shorstein, MD, explains how physicians at Kaiser Permanente have a streamlined regimen using a prophylactic drop-free drug before cataract surgery for more than a decade.
AAO 2020: Preventing cystoid macular oedema after cataract surgery
November 15th 2020AAO
Rudy Nuijts of the University Eye Clinic Maastricht, the Netherlands, discusses the highlights of his AAO 2020 presentation on a combination treatment regimen for lowering the incidence of cystoid macular oedema following category surgery.
AAO 2020: Alcon showcases advanced IOL technology for presbyopia
November 15th 2020AAO
Kristen Brotherson, vice president, US surgical marketing for Alcon, discusses some of the recent advances in cataract surgery-related technologies, including a new advanced lens for patients with presbyopia (AcrySof IQ Vivity IOL).